Net loss of Valiant Laboratories reported to Rs 0.51 crore in the quarter ended June 2024 as against net profit of Rs 4.27 crore during the previous quarter ended June 2023. Sales declined 63.28% to Rs 18.88 crore in the quarter ended June 2024 as against Rs 51.41 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales18.8851.41 -63 OPM %-12.617.43 - PBDT0.376.24 -94 PBT-0.165.78 PL NP-0.514.27 PL Powered by Capital Market - Live News

Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live News

Valiant Laboratories announced that the 3rd Annual General Meeting (AGM) of the company will be held on 8 August 2024.Powered by Capital Market - Live News

Net loss of Valiant Laboratories reported to Rs 1.24 crore in the quarter ended March 2024 as against net profit of Rs 7.83 crore during the previous quarter ended March 2023. Sales declined 65.98% to Rs 30.59 crore in the quarter ended March 2024 as against Rs 89.92 crore during the previous quarter ended March 2023.For the full year,net profit declined 98.90% to Rs 0.32 crore in the year ended March 2024 as against Rs 29.00 crore during the previous year ended March 2023. Sales declined 45.48% to Rs 182.06 crore in the year ended March 2024 as against Rs 333.91 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales30.5989.92 -66 182.06333.91 -45 OPM %-14.819.59 --4.6210.51 - PBDT-2.0510.31 PL 1.2039.70 -97 PBT-2.579.87 PL -0.7738.14 PL NP-1.247.83 PL 0.3229.00 -99 Powered by Capital Market - Live News

Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 14 May 2024Powered by Capital Market - Live News